Report #2896674

Received May 15, 2026

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex: Unknown
Age: Age unknown
State: —
Recovered: Unknown
Vaccinated: May 1, 2026
Onset: May 1, 2026
Days to onset: 0
Hospital days: —

Vaccines (1)

Type	Name	Manufacturer	Dose	Lot	Route / Site
VARZOS	ZOSTER (SHINGRIX)	GLAXOSMITHKLINE BIOLOGICALS	UNK	UNK	—

Symptoms (2)

DizzinessFatigue

Symptom narrative

tired; dizzy; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of tiredness in a patient who received Herpes zoster (Shingrix) for prophylaxis. In MAY-2026, the patient received Shingrix. In MAY-2026, more than a week after receiving Shingrix, the patient experienced tiredness (Verbatim: tired) and dizziness (Verbatim: dizzy). The outcome of the tiredness and dizziness were not reported. It was unknown if the reporter considered the tiredness and dizziness to be related to Shingrix. It was unknown if the company considered the tiredness and dizziness to be related to Shingrix. Additional Information: GSK Receipt Date: 12-MAY-2026 This case was reported by a patient via interactive digital media. The batch number was not provided and we and unable to contact the reporter.